Copyright Reports & Markets. All rights reserved.

Global Weight Loss Therapeutics Market Opportunities and Forecast 2022-2028

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Weight Loss Therapeutics Market Status and Forecast (2017-2028)
      • 1.3.2 Global Weight Loss Therapeutics Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Weight Loss Therapeutics Supply by Company

    • 2.1 Global Weight Loss Therapeutics Sales Value by Company
    • 2.2 Weight Loss Therapeutics Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Weight Loss Therapeutics Market Status by Type

    • 3.1 Weight Loss Therapeutics Type Introduction
      • 3.1.1 Appetite Suppression
      • 3.1.2 Increasing Body Metabolism
      • 3.1.3 Interfering with the Digestion Absorption Patterns
    • 3.2 Global Weight Loss Therapeutics Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Weight Loss Therapeutics Market Status by Application

    • 4.1 Weight Loss Therapeutics Segment by Application
      • 4.1.1 Hospitals
      • 4.1.2 Specialized Clinics
      • 4.1.3 Retail Pharmacies
      • 4.1.4 Mail Order Pharmacies
      • 4.1.5 Others
    • 4.2 Global Weight Loss Therapeutics Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Weight Loss Therapeutics Market Status by Region

    • 5.1 Global Weight Loss Therapeutics Market by Region
    • 5.2 North America Weight Loss Therapeutics Market Status
    • 5.3 Europe Weight Loss Therapeutics Market Status
    • 5.4 Asia Pacific Weight Loss Therapeutics Market Status
    • 5.5 Central & South America Weight Loss Therapeutics Market Status
    • 5.6 Middle East & Africa Weight Loss Therapeutics Market Status

    6 North America Weight Loss Therapeutics Market Status

    • 6.1 North America Weight Loss Therapeutics Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Weight Loss Therapeutics Market Status

    • 7.1 Europe Weight Loss Therapeutics Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Weight Loss Therapeutics Market Status

    • 8.1 Asia Pacific Weight Loss Therapeutics Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Weight Loss Therapeutics Market Status

    • 9.1 Central & South America Weight Loss Therapeutics Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Weight Loss Therapeutics Market Status

    • 10.1 Middle East & Africa Weight Loss Therapeutics Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Weight Loss Therapeutics Market Forecast by Type and by Application

    • 12.1 Global Weight Loss Therapeutics Sales Value Forecast (2023-2028)
    • 12.2 Global Weight Loss Therapeutics Forecast by Type
    • 12.3 Global Weight Loss Therapeutics Forecast by Application

    13 Global Weight Loss Therapeutics Market Forecast by Region/Country

    • 13.1 Global Weight Loss Therapeutics Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Zafgen
      • 14.1.1 Company Information
      • 14.1.2 Weight Loss Therapeutics Product Introduction
      • 14.1.3 Zafgen Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 VIVUS
      • 14.2.1 Company Information
      • 14.2.2 Weight Loss Therapeutics Product Introduction
      • 14.2.3 VIVUS Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Sanofi
      • 14.3.1 Company Information
      • 14.3.2 Weight Loss Therapeutics Product Introduction
      • 14.3.3 Sanofi Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Roche
      • 14.4.1 Company Information
      • 14.4.2 Weight Loss Therapeutics Product Introduction
      • 14.4.3 Roche Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Pfizer
      • 14.5.1 Company Information
      • 14.5.2 Weight Loss Therapeutics Product Introduction
      • 14.5.3 Pfizer Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Orexigen Therapeutics
      • 14.6.1 Company Information
      • 14.6.2 Weight Loss Therapeutics Product Introduction
      • 14.6.3 Orexigen Therapeutics Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Novo Nordisk
      • 14.7.1 Company Information
      • 14.7.2 Weight Loss Therapeutics Product Introduction
      • 14.7.3 Novo Nordisk Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Novartis AG
      • 14.8.1 Company Information
      • 14.8.2 Weight Loss Therapeutics Product Introduction
      • 14.8.3 Novartis AG Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Johnson & Johnson
      • 14.9.1 Company Information
      • 14.9.2 Weight Loss Therapeutics Product Introduction
      • 14.9.3 Johnson & Johnson Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 Eli Lilly
      • 14.10.1 Company Information
      • 14.10.2 Weight Loss Therapeutics Product Introduction
      • 14.10.3 Eli Lilly Weight Loss Therapeutics Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 Eisai
    • 14.12 Biocon
    • 14.13 Arena Pharmaceuticals
    • 14.14 Amgen
    • 14.15 Abbott

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Weight Loss Therapeutics market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Weight Loss Therapeutics industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to GRD Survey, the global Weight Loss Therapeutics market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Weight Loss Therapeutics Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Weight Loss Therapeutics market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Weight Loss Therapeutics Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Weight Loss Therapeutics industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Appetite Suppression
      Increasing Body Metabolism
      Interfering with the Digestion Absorption Patterns

      Segmented by Application
      Hospitals
      Specialized Clinics
      Retail Pharmacies
      Mail Order Pharmacies
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Zafgen
      VIVUS
      Sanofi
      Roche
      Pfizer
      Orexigen Therapeutics
      Novo Nordisk
      Novartis AG
      Johnson & Johnson
      Eli Lilly
      Eisai
      Biocon
      Arena Pharmaceuticals
      Amgen
      Abbott

      Buy now